Published-Ahead-of-Print November 8, 2005, DOI:10.2164/jandrol.05077
Journal of Andrology, Vol. 27, No. 2, March/April 2006
Copyright © American Society of Andrology
DOI: 10.2164/jandrol.05077
Sildenafil Improves Sleep-Related Erections in Hypogonadal Men: Evidence From a Randomized, Placebo-Controlled, Crossover Study of a Synergic Role for Both Testosterone and Sildenafil on Penile Erections
VINCENZO ROCHIRA,
ANTONIO BALESTRIERI,
BRUNO MADEO,
ANTONIO R. M. GRANATA AND
CESARE CARANI
From the Department of Medicine and Medical Specialties, Chair of
Endocrinology, University of Modena and Reggio Emilia, Modena, Italy.
|
Correspondence to: Dr Vincenzo Rochira, Department of Medicine and Medical
Specialties, Chair of Endocrinology, University of Modena and Reggio Emilia,
Via del Pozzo 71, 41100 Modena, Italy (e-mail:
rochira.vincenzo{at}unimore.it). |
To study the effects of sildenafil on human sleep-related erections
according to the state of androgenization, we evaluated the effects of
sildenafil on sleep-related erections in hypogonadal men before and during
testosterone replacement treatment and in control subjects. We enrolled 24
hypogonadal men and 24 healthy men as a control group. All hypogonadal
subjects had very low testosterone levels (<200 ng/dL [8.93 nmol/L]). All
subjects underwent nocturnal penile tumescence and rigidity monitoring (NPTRM)
for 3 consecutive nights and were randomly assigned to consume either 50 mg of
sildenafil or placebo 1 hour before bedtime on the second or third night of
nocturnal penile monitoring. The hypogonadal subjects were tested twice, first
without replacement treatment (H-T) and then after at least 6 months of
testosterone replacement therapy (H+T). The subjects of the control group (C)
were tested once. The following parameters of sleep-related erections were
analyzed: total number of valid erections, total duration of both rigidity
greater than or equal 70% and increase in penile circumference greater than or
equal 30 mm, maximum rigidity, and maximum increase in penile circumference.
NPTRM parameters were reduced in hypogonadal men before testosterone treatment
(H-T+P) when compared with control subjects taking placebo (C+P). NPTRM
parameters after testosterone (H+T+P) and sildenafil (H-T+S) administration
were similar to that of control subjects taking placebo (C+P). When the
statistical analysis was restricted to the hypogonadal men before testosterone
treatment, sildenafil alone significantly increased NPTRM parameters when
compared with placebo (H-T+S vs H-T+P). Testosterone restored normal erections
when administered to hypogonadal subjects (H+T+P vs H-T+P); in hypogonadal
men, however, the combined treatment (sildenafil plus testosterone) resulted
in the maximum positive effect on NPTRM parameters. When the increase from
baseline was analyzed, the effects of testosterone plus sildenafil were
greater than the sum of the effects of each drug used alone. In conclusion,
sildenafil administered at bedtime improves sleep-related erections in
hypogonadal men, suggesting that the nitric oxide pathway may be
pharmacologically enrolled and enhanced despite low serum testosterone.
Furthermore, these data strongly support the idea of a synergic effect on
sleep-related erections of sildenafil and testosterone.
Key words: Nitric oxide pathway, androgen, hypogonadism, penile rigidity and tumescence, nocturnal erection, PDE5, NPT
This article has been cited by other articles:

|
 |

|
 |
 
F Jockenhovel, T Minnemann, M Schubert, S Freude, D Hubler, C Schumann, A Christoph, and M Ernst
Comparison of long-acting testosterone undecanoate formulation versus testosterone enanthate on sexual function and mood in hypogonadal men
Eur. J. Endocrinol.,
May 1, 2009;
160(5):
815 - 819.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2006 by The American Society of Andrology.